Multidrug infusion for pain control
US10350203B2 · kind B2 · utility
1Cited by
0References
4Claims
0Family size
Inventor
Key dates
| Filing date | May 18, 2016 |
| Grant date | Jul 16, 2019 |
| Priority date | — |
| Expiry date | May 18, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0085
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a formulation comprising an opioid, a Na channel blocker, an alpha2-receptor agonist, an opioid mu or delta receptor competitive antagonist and an intravenous anesthetic and/or a neurologic acting agent for use in pain control and/or cognitive function improvement.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.